Preoperative therapy with pazopanib in high-risk soft tissue sarcoma: a phase II window-of-opportunity study by the German Interdisciplinary Sarcoma Group (GISG-04/NOPASS)-Reference-Cited by-同舟云学术

Preoperative therapy with pazopanib in high-risk soft tissue sarcoma: a phase II window-of-opportunity study by the German Interdisciplinary Sarcoma Group (GISG-04/NOPASS)

Published:2016-01 Issue:1 Volume:6 Page:e009558
ISSN:2044-6055
Container-title:BMJ Open
language:en
Short-container-title:BMJ Open

Author:

Ronellenfitsch Ulrich,Dimitrakopoulou-Strauss Antonia,Jakob Jens,Kasper Bernd,Nowak Kai,Pilz Lothar R,Attenberger Ulrike,Gaiser Timo,Egerer Gerlinde,Fröhling Stefan,Derigs Hans-Günter,Schwarzbach Matthias,Hohenberger Peter

Publisher

BMJ

Subject

General Medicine

Reference40 articles.

1. Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;ESMO/European Sarcoma Network Working Group;Ann Oncol,2014

2. Neoadjuvant treatment of locally advanced soft tissue sarcoma of the limbs: which treatment to choose?;Hohenberger;Oncologist,2008

3. A randomised phase II study on neo-adjuvant chemotherapy for ‘high-risk’ adult soft-tissue sarcoma;Gortzak;Eur J Cancer,2001

4. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study;Issels;Lancet Oncol,2010

5. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial;O'Sullivan;Lancet,2002

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular and Pathological Profiling of Corresponding Treatment-Naïve and Neoadjuvant Pazopanib-Treated High-Risk Soft Tissue Sarcoma Samples of the GISG-04/NOPASS Study;Biology;2021-07-09

2. Pazopanib in metastatic soft tissue sarcomas: Testing the waters in developing world;Indian Journal of Cancer;2021

3. Neoadjuvant Pazopanib Treatment in High-Risk Soft Tissue Sarcoma: A Quantitative Dynamic 18F-FDG PET/CT Study of the German Interdisciplinary Sarcoma Group;Cancers;2019-06-08

4. Pazopanib in advanced soft tissue sarcomas;Signal Transduction and Targeted Therapy;2019-05-17

5. Preoperative Pazopanib in High-Risk Soft Tissue Sarcoma: Phase II Window-of Opportunity Study of the German Interdisciplinary Sarcoma Group (NOPASS/GISG-04);Annals of Surgical Oncology;2019-03-06